New hope for hepatitis b: experimental drug Tune-401 enters human testing

NCT ID NCT06671093

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 27 times

Summary

This early-stage study tests the safety of a new drug, Tune-401, in 36 adults with chronic hepatitis B. Participants must already be on standard antiviral therapy. The main goal is to see if the drug is safe and how the body processes it. This is not a cure, but a step toward better control of the infection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • New Zealand Clinical Research

    RECRUITING

    Auckland, 1010, New Zealand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • PMSI Republican Clinical Hospital "Timofei Mosneaga", Arensia Exploratory Medicine Phase I Unit

    RECRUITING

    Chisinau, MD2025, Moldova

    Contact

  • Queen Mary Hospital, University of Hong Kong

    RECRUITING

    Hong Kong, Hong Kong

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.